AI growth masks sequential deceleration, margin under pressure

Delivered ₹72,275Cr YoY +13.9%, QoQ +2.2% in rupee terms

Delivered OPM 24.8%; 170 bps wage impact offset by 40 bps currency = ~130 bps net decline

Delivered NPM 18.2% (13420/72275). Call reported 19.2%, a 100 bps overstatement

Delivered PAT 13420Cr YoY +4.7%, QoQ -2.6% corroborates call

Call states 2.2% QoQ growth and 13.9% YoY; no prior quarter data provided to verify streak

Prior Q4 call acknowledged 'headwinds'; Q1 reveals wage inflation is structural, not temporary. Management committing to 25%+ margin target implies acceptance of structural margin floor at ~24-24.5%.

Prior call spoke of 'broad-based growth'; Q1 reveals Consumer (airlines, retail) and Life Sciences declining, driven by geopolitical uncertainty and macro caution. Weakness expected to persist into Q2.

SKF $800M + ServiceNow partnership + ABB deal show AI-led transformation is resonating. Compared to prior guidance of 'strong order book', the TCV of $9.5B this Q and mega deal momentum validate the thesis.

Prior call framed as 'fourth consecutive quarter of growth'; actual 2.2% QoQ is the slowest rate, contradicting momentum narrative. PAT contracted -2.6% QoQ.

Geopolitical uncertainty started in March, continued through Q1; clients deferred projects. Expect demand recovery in Q2 due to pent-up tech backlog; generally optimistic on Q2.

Investments on talent, partnerships, and M&A charges; no granular breakdown provided; noted cost category refinement removed COR/SG&A split.

Difficult to quantify which business segment benefited; productivity gains ~10-15% when leveraged; customers usually offset gains with additional work rather than price cuts.

AI is non-recurring; projects are 1-2 quarters; lumpy by nature; happy with QoQ growth trajectory despite non-recurring nature.

Won't put a number on FDEs today (transition period); aim for at least 1% of employee base in new operating model going forward; definition still evolving.

Can't quantify rate of change; conversations show Life Sciences uptick and some verticals showing stronger pull; confident but not quantifiable.

Large projects ended this Q; new project ramp insufficient to offset declines; as deals mature, will see growth.

Sector-specific: BFSI strong; retail/consumer impacted by geopolitics; manufacturing weak due to auto/tariffs. Multiple factors, not broad-based caution.

Don't agree with drastic reduction narrative; roles will change (prompt engineering, model training, lifecycle mgmt); want top talent available for immediate deployment.

6 mega deals in 5Q; all cut across industries; key: optimize run + business transformation bundled; AI brought earlier into day-1 execution; acceleration comes from discretionary transformation projects.

Most enterprises will have multiple models; model FinOps and on-prem vs. cloud decision-making critical; GSI has greater role to ensure money well spent.

Very marginal shift toward AI transformative deals; not a significant mix change.

Output-commitment models, outcome-based (fixed duration, business outcome), fixed-price fixed-capacity ('AI lab'), some T&M with outcome accountability. Especially in agentic GBS, shift to outcome-based commitment increasing.

Balance growth investment with operating discipline; reinvesting gains into capabilities; progressive inch-up toward FY26 levels; no specific timeline given.

170 bps overall wage impact; segment-level variations due to vertical-specific investments; wage impact is the primary driver across segments.

14,000 campus graduates onboarded last quarter; visiting universities; hiring for AI-native skills; no specific FY target given.

Productivity gains spread over project tenure; compensated by additional customer opportunities; don't see $1T contraction happening in reality; headcount increased this quarter.

Management frames outlook as 'demand recovery in Q2 from pent-up backlog' and 'confident TCS well-positioned to convert demand into stronger growth as client spend normalizes.'

Q1 at 24.8% shows margin headwind (wage hikes 170 bps); management says 'progressive inch-up closer to FY26 levels'; timeline vague; investments to continue offsetting gains.

No capex number disclosed; framed as reinvestment of profitability gains into long-term competitiveness; pyramid optimization, automation to offset.

Geopolitical uncertainty starting March continued through Q1; clients deferring projects. Consumer (airlines, retail) and some manufacturing exposed. Recovery dependent on sentiment shift; timeline unclear.

170 bps wage hike impact per quarter; only 40 bps offset by currency and efficiencies. Management targets 25%+ but Q1 at 24.8% shows headwind. Ongoing wage pressure from fresh hiring and upskilling investments.

AI revenue $2.6B annualized comprises 1-2 quarter project spikes. Q1 added $75M incremental vs. $125M prior Q; acknowledged as lumpy. Sustainability as annuity base uncertain.

2.2% QoQ revenue growth is the slowest rate of the 'fourth consecutive quarter of growth' claim. PAT contracted -2.6% QoQ despite flat growth. Suggests underlying demand softness beneath headline YoY strength.

Life Sciences declined this Q; Manufacturing softness in auto; management expects recovery in Q2 but no quantified improvement path or timing certainty.